Clinical Trial

A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

Study acronym: UP-SPOUT
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
A Randomized, Placebo-controlled, Multicenter, Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients with Active Psoriatic Arthritis (UP-SPOUT)
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-06-06; most recent amendment 2026-03-30.
Status change: Not Yet Recruiting → Recruiting 2025-02-10
Trial Details
NCT Number NCT06454188
Lead Sponsor CARE ARTHRITIS LTD.
Collaborators: AbbVie
Conditions Psoriatic Arthritis, Spondyloarthritis, Axial
Enrollment 100 participants
Start Date 2024-12-03
Primary Completion 2028-09 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-03